A Multicenter, Observational, Non-interventional Registry Designed to Collect Clinical Data in Chinese Patients Who Have Received CUBICIN® Treatment Under Condition of Actual Usage in Clinical Practice
Sponsor study identifier
observational
203
1 country
18
Study Start
January 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2012
Actual (reported)Study Completion
November 2012
Actual (reported)This is a Multicenter, observational, non-interventional registry designed to collect clinical data in Chinese patients who have received CUBICIN treatment under condition of actual usage in clinical practice.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2012
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 16, 2010
Actual (reported)September 30, 2010
Actual (reported)January 2011
Date type not reportedThis date has not been verified as actual or estimated.
November 2012
Actual (reported)November 2012
Actual (reported)AEs of CUBICIN therapy
2 weeks
clinical response of CUBICIN therapy at each available time point
2 weeks
CPK level monitoring and results
2 weeks
treatment duration
2 weeks
Time to clinical response
2 weeks
Chinese patients received CUBICIN treatment
Research Site
Beijing, Beijing Municipality, China
Research Site
Fuzhou, Fujian, China
Research Site
Xiamen, Fujian, China
Research Site
Zhangzhou, Fujian, China
Research Site
Guangzhou, Guangdong, China
Research Site
Xingtai, Hebei, China
Research Site
Haerbing, Heilongjiang, China
Aixia Wang, Prof.
Peiking Union Medical College Hospital
Karen Atkin
AstraZeneca
Mentha Wang
AstraZeneca
203 participants (actual enrollment reported by the registry).
First Submitted
September 16, 2010
First Posted
September 30, 2010
Study Start
January 2011
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Research Site
Zhenzhou, Henan, China
Research Site
Wuhan, Hubei, China
Research Site
Changzhou, Jiangsu, China
Research Site
Nanjing, Jiangsu, China
Research Site
Nantong, Jiangsu, China
Research Site
Suzhou, Jiangsu, China
Research Site
Dalian, Liaoning, China
Research Site
Shanghai, Shanghai Municipality, China
Research Site
Chengdu, Sichuan, China
Research Site
Tianjin, Tianjin Municipality, China
Research Site
Kunming, Yunnan, China
Primary Completion
November 2012
Actual (reported)Study Completion
November 2012
Actual (reported)Last Updated
November 27, 2012
Record last verified: 2012-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: